viral
infect
affect
wheez
asthma
children
adult
age
infanc
wheez
ill
usual
viral
origin
children
sever
wheez
episod
like
develop
recurr
episod
asthma
develop
asthma
later
childhood
etiolog
viral
infect
affect
prognosi
preschool
children
wheez
human
rhinovirus
hrv
particularli
like
subsequ
develop
asthma
major
risk
factor
asthma
age
group
earli
onset
sensit
respiratori
allergi
older
children
adult
viral
respiratori
ill
rel
mild
yet
contribut
acut
potenti
sever
exacerb
patient
asthma
fact
consider
evid
viral
respiratori
infect
respiratori
allergi
two
signific
risk
factor
exacerb
lead
acut
care
visit
hospit
find
underlin
import
understand
synergist
natur
allerg
sensit
infect
hrv
infant
rel
onset
asthma
children
adult
respect
exacerb
asthma
articl
review
clinic
evid
interact
discuss
experiment
evid
theori
relat
immunolog
respons
respiratori
virus
allerg
airway
inflamm
pathogenesi
diseas
activ
asthma
hrv
classifi
serotyp
base
growth
tissu
cultur
inhibit
specif
antisera
canon
strain
classifi
group
b
base
similar
partial
genet
sequenc
respons
certain
antivir
medic
data
studi
use
molecular
diagnost
us
australia
asia
europ
demonstr
least
hrv
strain
previous
appreci
analysi
full
genom
sequenc
newli
identifi
hrv
indic
major
belong
uniqu
speci
design
like
sever
newli
discov
respiratori
virus
grow
standard
tissu
cultur
characterist
explain
discoveri
requir
develop
molecular
diagnost
hrv
small
nm
diamet
virus
picornavirida
famili
contain
singl
strand
rna
translat
directli
protein
posit
strand
viral
capsid
compos
four
protein
assembl
protom
capsid
contain
protom
variat
structur
protein
particularli
account
larg
number
viral
serotyp
strain
capsid
bind
specif
protein
surfac
airway
cell
hrv
serotyp
bind
intercellular
adhes
other
bind
member
lipoprotein
receptor
analysi
limit
number
genom
suggest
probabl
bind
uniqu
cellular
receptor
recent
grown
vitro
cultur
sinu
mucos
biopsi
specimen
organ
cultur
system
use
demonstr
virus
bind
receptor
distinct
use
hrv
bound
cell
hrv
intern
endosom
acidif
compart
lead
dissoci
protein
rest
capsid
initi
releas
hrv
rna
cell
permiss
airway
epitheli
cell
viral
rna
translat
singl
polyprotein
hrv
proteas
direct
process
polyprotein
matur
protein
structur
protein
hrv
polymeras
direct
rna
replic
viral
rna
present
cell
process
suffici
quantiti
posit
strand
rna
capsid
protein
synthes
progeni
virion
assembl
releas
upon
lysi
cell
addit
help
direct
replic
viral
protein
also
inhibit
host
cell
process
favor
viral
replic
exampl
proteas
cleav
eukaryot
translat
initi
factor
gamma
ribosom
protein
complex
prevent
translat
cap
rna
major
cellular
mrna
contrast
hrv
genom
rna
structur
known
intern
ribosom
entri
site
ire
bind
ribosom
complex
independ
translat
hrv
rna
unimped
proteas
also
cleav
nuclear
pore
protein
imped
commun
nucleu
cytoplasm
one
consequ
activ
cellular
rna
level
may
reflect
protein
synthesi
hrv
infect
also
inhibit
transcript
cellular
rna
viral
rna
like
mani
virus
evid
hrv
develop
mechan
inhibit
antivir
respons
cleav
protein
involv
viru
recognit
pathway
transcript
factor
relat
antivir
chemokin
respons
eg
hrv
infect
transmit
either
aerosol
droplet
contact
infect
secret
transmiss
hrv
infect
adult
gener
requir
prolong
contact
infant
young
children
effect
vector
readili
transmit
hrv
infect
within
famili
respiratori
symptom
typic
develop
day
inocul
studi
earli
sign
cold
includ
sore
scratchi
throat
malais
follow
thin
mucoid
discharg
sneez
congest
thicker
nasal
secret
increas
mucu
peak
cold
uncompl
hrv
infect
usual
peak
day
inocul
resolv
week
inocul
infect
last
week
longer
seem
improv
worsen
repres
either
serial
infect
differ
cold
virus
els
secondari
bacteri
infect
follow
initi
viral
infect
hrv
infect
often
detect
asymptomat
infant
less
commonli
adult
viral
detect
without
symptom
repres
begin
end
infect
true
asymptomat
infect
immun
compet
individu
carrier
state
hrv
discoveri
rais
new
question
whether
infect
speci
virus
caus
distinct
pattern
ill
virus
close
associ
wheez
ill
infant
pneumonia
young
children
number
clinic
studi
addit
virus
frequent
detect
exacerb
asthma
children
evid
caus
sever
wheez
episod
compar
hrv
epidemiolog
complex
strain
hrv
circul
commun
singl
season
prevail
hrv
strain
differ
accord
season
locat
shift
almost
complet
year
year
complex
hrv
epidemiolog
larg
number
hrv
strain
indic
studi
requir
determin
whether
inde
virul
hrv
strain
infect
establish
respiratori
symptom
result
two
process
destruct
normal
airway
tissu
due
direct
effect
viru
immun
respons
infect
damag
epithelium
disturb
airway
physiolog
number
differ
pathway
exampl
epitheli
edema
shed
togeth
mucu
product
caus
airway
obstruct
wheez
furthermor
hrv
infect
inhibit
process
associ
epitheli
repair
addit
viral
replic
initi
innat
immun
respons
within
epitheli
cell
includ
induct
interferon
ifn
antivir
effector
chemokin
recruit
inflammatori
cell
airway
recent
develop
rodent
model
infect
hrv
relat
picornavirus
provid
system
test
theori
immunopathogenesi
vivo
identif
antivir
respons
determin
suscept
hrv
studi
number
laboratori
virus
hrv
infect
rel
cell
airway
inflammatori
respons
infect
import
contributor
respiratori
symptom
major
cell
recruit
airway
acut
cold
neutrophil
smaller
number
mononuclear
cell
studi
eosinophil
product
neutrophil
activ
like
involv
obstruct
airway
caus
lower
airway
symptom
exampl
releas
potent
secretagogu
elastas
activ
neutrophil
upregul
goblet
cell
secret
mucu
addit
chang
neutrophil
nasal
secret
relat
respiratori
symptom
increas
airway
hyperrespons
enhanc
bronchoconstrict
respons
irrit
key
featur
asthma
find
suggest
one
strategi
reduc
sever
viral
ill
might
moder
neutrophil
inflammatori
respons
moreov
mononuclear
cell
recruit
upper
lower
airway
earli
stage
viral
respiratori
infect
serv
limit
extent
infect
clear
epitheli
cell
consist
report
sever
viral
lower
respiratori
infect
immunocompromis
patient
number
risk
factor
sever
hrv
ill
identifi
clinic
studi
studi
volunt
inocul
virus
control
condit
tabl
factor
includ
characterist
host
young
elderli
individu
chronic
lung
diseas
tend
wors
ill
hrv
infect
interestingli
boy
like
develop
moder
sever
hrv
ill
earli
childhood
consider
interest
defin
relationship
pattern
antivir
respons
ill
outcom
especi
ifn
factor
relat
atopi
asthma
relationship
discuss
detail
later
review
final
environment
lifestyl
factor
associ
sever
common
cold
includ
pollut
smoke
characterist
immun
respons
stress
diet
notabl
data
suggest
supplement
either
probiot
vitamin
could
reduc
frequenc
sever
common
cold
wheez
ill
close
associ
viral
respiratori
infect
age
group
fig
approxim
half
infant
experi
wheez
studi
use
sensit
viral
diagnost
indic
wheez
ill
caus
plethora
respiratori
virus
tabl
sever
end
ill
spectrum
known
bronchiol
includ
mani
clinic
featur
acut
asthma
includ
wheez
rapid
breath
sometim
hypoxia
hypoventil
respiratori
syncyti
viru
rsv
particularli
like
caus
lower
respiratori
tract
infect
account
half
case
bronchiol
winter
month
interestingli
although
respiratori
virus
less
like
caus
sever
ill
clinic
manifest
infect
rhiniti
cough
case
wheez
pretti
similar
remark
given
major
differ
structur
virus
replic
cycl
extent
immun
respons
recent
studi
use
molecular
diagnost
demonstr
hrv
common
caus
lower
respiratori
tract
infect
infant
young
children
recognit
hrv
lower
airway
pathogen
departur
origin
character
viru
exclus
caus
common
cold
soon
discoveri
hrv
found
replic
best
rel
cool
temperatur
assum
infect
limit
upper
airway
although
lung
parenchyma
core
temperatur
airway
consider
cooler
temperatur
larg
medium
size
airway
ideal
hrv
replic
fact
hrv
detect
lower
airway
fluid
cell
experiment
infect
upper
airway
furthermor
consider
clinic
evid
link
hrv
infect
lower
respiratori
infect
children
includ
hospit
pneumonia
recent
studi
children
year
age
found
hrv
detect
children
hospit
respiratori
symptom
fever
hospit
rate
especi
high
infant
children
asthma
find
suggest
possibl
infect
hrv
like
rsv
respiratori
virus
directli
injur
airway
tissu
acut
infect
one
featur
distinguish
hrv
respiratori
virus
larg
number
distinct
strain
includ
tradit
serotyp
estim
speci
virus
group
genotyp
result
hrv
infect
occur
frequent
young
children
children
prone
wheez
respiratori
virus
experi
recurr
episod
wheez
distinct
hrv
strain
third
infant
acut
wheez
ill
go
develop
recurr
wheez
lead
specul
viral
respiratori
ill
earli
life
promot
asthma
causal
role
virus
asthma
seem
plausibl
lung
immun
system
grow
develop
infanc
might
especi
vulner
pathogen
period
time
altern
also
possibl
relationship
causal
wheez
episod
instead
reveal
preexist
tendenc
asthma
secondari
impair
lung
physiolog
antivir
respons
fact
immunolog
risk
factor
sever
viral
respiratori
ill
identifi
discuss
detail
later
chapter
theori
suggest
children
either
born
soon
acquir
abnorm
lung
physiolog
infect
respiratori
viru
hrv
present
first
noxiou
stimulu
provok
wheez
third
possibl
combin
element
first
two
two
hit
hypothesi
viral
infect
promot
asthma
mainli
predispos
children
exampl
infant
predispos
poor
antivir
respons
would
develop
sever
ill
infect
respiratori
virus
sever
infect
could
lead
increas
damag
lower
airway
particularli
import
growth
phase
lung
accord
hypothesi
recurr
lower
respiratori
infect
could
hinder
proper
lung
growth
develop
lead
chang
airway
structur
eg
fibrosi
promot
asthma
line
reason
support
experiment
find
infect
virus
rsv
hrv
vivo
vitro
increas
synthesi
factor
influenc
lung
growth
develop
repair
pathophysiolog
asthma
close
relat
airway
remodel
collect
featur
reflect
structur
chang
airway
promot
acut
chronic
airway
obstruct
structur
chang
includ
hypertrophi
airway
smooth
muscl
increas
fibrosi
reduc
barrier
function
increas
number
cell
prolifer
airway
vasculatur
within
epithelium
chang
airway
structur
present
wheez
infant
appear
develop
childhood
addit
acut
infect
hrv
virus
induc
synthesi
factor
regul
airway
growth
angiogenesi
fibrosi
repair
tabl
furthermor
viral
infect
upregul
neurotropin
regul
develop
airway
neural
network
effect
neural
mechan
could
affect
bronchoconstrict
respons
irrit
includ
futur
viral
infect
fact
increas
sensit
inhal
irrit
aka
bronchial
hyperrespons
key
featur
asthma
singl
repeat
bout
overexpress
regul
lung
develop
remodel
affect
ultim
lung
structur
function
known
interest
regard
effect
viral
infect
lung
function
asthma
question
may
best
address
anim
model
model
studi
effect
hrv
infect
mous
publish
well
method
serial
passag
mous
epitheli
cell
propag
hrv
addit
mengoviru
anoth
member
picornavirida
famili
natur
rodent
pathogen
caus
system
infect
resembl
polioviru
viru
attenu
replic
kill
epitheli
cell
inocul
airway
replic
sever
day
caus
mild
respiratori
ill
resembl
hrv
infect
human
number
risk
factor
develop
asthma
recurr
wheez
first
year
life
identifi
studi
demonstr
infant
hospit
bronchiol
increas
risk
develop
asthma
later
childhood
risk
increas
famili
histori
asthma
develop
allerg
diseas
allerg
rhiniti
atop
dermat
blood
eosinophilia
male
gender
sever
predict
indic
incorpor
risk
factor
develop
order
estim
prognosi
infant
recurr
wheez
specif
etiolog
wheez
episod
also
influenc
risk
subsequ
asthma
sever
studi
suggest
infant
wheez
hrv
may
especi
high
risk
subsequ
asthma
exampl
case
control
studi
conduct
finland
demonstr
infant
hospit
wheez
found
particularli
high
risk
subsequ
asthma
relationship
persist
least
adolesc
find
support
result
two
birth
cohort
studi
childhood
origin
asthma
coast
studi
birth
cohort
studi
famili
least
one
parent
allergi
asthma
enrol
prenat
immun
develop
respiratori
ill
prospect
evalu
use
diagnost
viral
etiolog
identifi
wheez
ill
notabl
moder
sever
hrv
infect
without
wheez
infanc
signific
risk
factor
odd
ratio
persist
wheez
age
year
moreov
hrv
wheez
ill
first
year
life
significantli
associ
develop
asthma
age
year
combin
allerg
sensit
wheez
age
year
associ
highest
risk
develop
asthma
similarli
australian
birth
cohort
studi
kusel
colleagu
enrol
babi
compar
viral
respiratori
ill
first
year
life
subsequ
respiratori
outcom
wheez
ill
either
hrv
rsv
infanc
associ
asthma
age
year
interestingli
associ
signific
children
earli
onset
age
year
allerg
sensit
collect
result
highlight
role
wheez
infanc
hrv
particular
determin
risk
subsequ
asthma
decad
clinician
suspect
respiratori
infect
major
caus
asthma
exacerb
character
acut
onset
obstruct
small
airway
lead
clinic
manifest
wheez
short
breath
begin
studi
util
polymeras
chain
reaction
pcr
viral
diagnost
found
viral
respiratori
infect
detect
exacerb
asthma
children
half
exacerb
adult
furthermor
approxim
infect
associ
asthma
exacerb
caus
hrv
similar
find
report
children
adult
hospit
acut
asthma
exacerb
asthma
season
temper
climat
strong
peak
asthma
morbid
septemb
shortli
children
return
school
also
spring
spring
fall
peak
hospit
correspond
close
pattern
hrv
isol
within
commun
suggest
causal
relationship
contrast
influenza
rsv
infect
like
associ
acut
asthma
symptom
wintertim
interest
individu
asthma
necessarili
cold
neither
sever
durat
upper
respiratori
symptom
enhanc
experiment
hrv
infect
adult
asthma
contrast
find
upper
airway
prospect
studi
cold
coupl
consist
one
asthmat
one
normal
individu
demonstr
cold
caus
greater
durat
sever
lower
respiratori
symptom
subject
asthma
find
suggest
differ
express
respiratori
viral
infect
specif
lower
airway
studi
provid
evid
strong
relationship
viral
infect
particularli
due
hrv
acut
exacerb
asthma
instanc
exacerb
caus
multipl
factor
accordingli
hrv
inocul
volunt
stabl
asthma
usual
provok
acut
asthma
symptom
factor
commonli
contribut
exacerb
asthma
allergi
allergen
exposur
indoor
pollut
eg
tobacco
smoke
outdoor
pollut
eg
particul
ozon
stress
infect
eg
sinus
addit
lack
use
asthma
control
medic
persist
asthma
associ
increas
risk
exacerb
factor
also
associ
increas
sever
cold
absenc
asthma
tabl
suggest
possibl
may
enhanc
viral
replic
amplifi
effect
inflamm
allergi
appear
strongest
risk
factor
develop
exacerb
asthma
exampl
studi
perform
tertiari
pediatr
emerg
depart
allergi
viral
infect
commonli
hrv
identifi
risk
factor
wheez
children
hrv
infect
detect
combin
either
eosinophilia
posit
radioallergosorb
test
rast
common
aeroallergen
strongest
odd
wheez
addit
recent
studi
perform
routin
sampl
nasal
secret
children
asthma
period
peak
hrv
preval
approxim
children
also
sensit
respiratori
allergen
allerg
sensit
associ
similar
rate
viral
detect
nasal
secret
children
allerg
asthma
ill
greater
durat
sever
like
experi
loss
asthma
control
moder
asthma
exacerb
studi
test
whether
allergen
exposur
increas
risk
wheez
children
adult
allerg
asthma
studi
asthmat
admit
acut
exacerb
versu
stabl
asthmat
patient
hospit
diagnos
significantli
higher
proport
children
hospit
acut
exacerb
infect
respiratori
viru
compar
children
stabl
asthma
children
hospit
admiss
p
combin
allerg
sensit
allergen
exposur
also
found
frequent
asthma
hospit
compar
two
control
group
respect
p
multivari
analysi
combin
risk
factor
dramat
increas
risk
hospit
admiss
p
demonstr
synergist
relationship
similar
find
report
studi
adult
combin
sensit
high
exposur
one
indoor
allergen
viral
detect
consider
increas
risk
admit
hospit
asthma
odd
ratio
confid
interv
p
final
inner
citi
asthma
studi
ica
children
sensit
highli
expos
cockroach
allergen
like
admit
hospit
unschedul
medic
visit
time
school
either
children
virolog
perform
ica
presum
viral
infect
import
contributor
asthma
morbid
popul
consider
interest
determin
whether
respiratori
virus
pathogen
bacteria
work
togeth
destabil
chronic
lung
condit
addit
provok
acut
exacerb
asthma
hrv
infect
also
increas
lower
airway
obstruct
individu
chronic
airway
diseas
chronic
obstruct
lung
diseas
copd
cystic
fibrosi
whether
allergi
also
play
role
exacerb
disord
determin
tradit
observ
viral
uri
lri
commonli
preced
bacteri
infect
mechan
viral
infect
promot
secondari
bacteri
infect
describ
recent
convers
mechan
receiv
lot
attent
bacteri
infect
colon
increas
suscept
viral
respiratori
infect
ill
interestingli
individu
copd
requir
small
amount
viru
induc
moder
cold
experiment
inocul
moreov
new
genom
techniqu
disprov
longstand
assumpt
lower
airway
steril
two
recent
studi
indic
uniqu
featur
lower
airway
flora
asthma
final
colon
upper
airway
bacteri
pathogen
first
month
life
relat
wheez
increas
risk
subsequ
asthma
collect
find
suggest
virus
bacteria
may
interact
determin
risk
onset
asthma
causat
acut
exacerb
children
adult
establish
diseas
airway
epithelia
cover
entir
surfac
respiratori
tract
contact
air
function
barrier
potenti
pathogen
foreign
particl
epitheli
cell
primari
import
viral
respiratori
infect
serv
host
cell
viral
replic
also
initi
innat
immun
respons
demonstr
cell
may
becom
infect
viral
infect
exampl
airway
smooth
muscl
cell
infect
viru
tissu
cultur
suggest
potenti
mechan
viral
infect
caus
bronchospasm
airway
hyperrespons
although
yet
verifi
vivo
hrv
also
replic
readili
fibroblast
vitro
suggest
infect
could
involv
fibroblast
airway
epithelium
compromis
earlier
work
cytokin
releas
follow
hrv
infect
focus
epitheli
cell
cell
princip
site
viru
replic
internalizationrepl
viral
rna
appear
necessari
optim
epitheli
cell
mediat
releas
howev
hrv
infect
small
proport
epitheli
cell
becom
infect
cytokin
level
vivo
markedli
elev
find
suggest
cell
type
andor
mechan
besid
direct
cytokin
releas
epitheli
cell
critic
airway
respons
hrv
epitheli
cell
fibroblast
close
contact
basement
membran
macrophag
dendrit
cell
dc
contact
epitheli
cell
lumen
within
epitheli
tissu
respect
moreov
activ
monocyt
cell
repres
earli
step
natur
immun
toward
viral
infect
close
contact
monocyt
cell
upper
lower
airway
epithelium
suggest
cell
influenc
immun
respons
hrv
vivo
could
relev
asthma
exacerb
varieti
experiment
model
includ
experiment
cold
studi
ex
vivo
hrv
infect
studi
anim
model
system
use
defin
cell
cytokin
involv
regul
inflammatori
respons
hrv
infect
nasal
lavag
sampl
patient
experienc
first
sign
natur
cold
day
postsymptom
reveal
increas
bradykinin
lysylbradykinin
potent
vasoact
peptid
whose
level
correl
vascular
permeabl
furthermor
increas
level
proinflammatori
cytokin
nasal
secret
volunt
experiment
induc
cold
correl
concentr
kinin
sever
cold
levandowski
colleagu
found
direct
correl
nasopharyng
symptom
percentag
lymphocyt
phagocyt
eg
monocyt
nasal
secret
induc
cold
respons
consist
observ
nasal
secret
includ
increas
level
chemokin
ifn
protein
kda
gener
concentr
cytokin
mediat
correl
reason
well
viral
replic
symptom
score
acut
cold
experiment
infect
also
use
gain
addit
insight
differ
respons
upper
lower
airway
volunt
allergi
andor
stabl
asthma
one
key
question
whether
hrv
provok
asthma
infect
lower
airway
mechan
link
infect
upper
airway
potenti
system
lung
inflammatori
respons
tissu
cultur
hrv
appear
replic
least
well
perhap
even
better
epitheli
cell
deriv
either
upper
versu
lower
airway
addit
hrv
detect
lower
airway
cell
secret
situ
hybrid
immunostain
mucos
biopsi
experiment
inocul
follow
experiment
inocul
adult
level
viru
detect
sputum
equal
exceed
viru
detect
nasal
secret
whether
asthma
present
final
hrv
infect
produc
lower
airway
inflamm
includ
increas
neutrophil
bronchial
lavag
fluid
influx
cell
eosinophil
lower
airway
epithelium
enhanc
epitheli
express
find
provid
strong
evid
hrv
replic
larg
lower
airway
suggest
cellular
inflamm
mucu
tissu
edema
could
directli
induc
airway
obstruct
closur
recent
gener
mous
model
studi
system
effect
hrv
infect
hrv
differ
cellular
target
receptor
bind
minor
group
hrv
bind
murin
low
densiti
lipoprotein
receptor
ldlr
major
group
hrv
serotyp
bind
human
rodent
thu
develop
transgen
mous
possess
chimer
necessari
studi
major
group
hrv
serotyp
mice
agreement
human
studi
major
group
hrv
infect
human
transgen
mice
lead
increas
detect
neutrophil
lymphocyt
lung
respons
also
observ
lung
mice
minor
group
hrv
administr
addit
inocul
mice
minor
group
hrv
induc
expressionreleas
mucin
ifn
famili
member
similar
rang
cytokin
chemokin
one
limit
mous
model
viral
replic
occur
rel
brief
period
time
h
compar
day
human
mous
model
use
explor
mechan
viru
effect
allerg
airway
inflamm
allerg
sensit
hrv
infect
increas
infiltr
numer
leukocyt
includ
neutrophil
eosinophil
macrophag
increas
airway
cholinerg
hyperrespons
macrophag
deplet
mice
hrv
infect
result
diminish
airway
respons
reduc
eosinophil
recruit
lung
support
role
macrophag
cellular
inflamm
associ
hrv
infect
hrv
treat
macrophag
mice
exhibit
increas
express
altern
activ
macrophag
marker
ie
suggest
subset
macrophag
contribut
enhanc
inflammatori
respons
viru
context
allergi
rhinoviru
infect
occur
mainli
endocytosi
major
strain
bind
refer
major
group
hrv
approxim
strain
bind
instead
bind
member
ldlr
famili
specif
ldlr
ldlr
vldlr
andor
protein
lrp
refer
minor
group
rhinovirus
mani
lab
util
util
solubl
antibodi
prevent
hrv
bind
cell
initi
cellular
signal
addit
viral
rna
damag
treatment
neutral
red
dye
treatment
preserv
viral
bind
sever
inhibit
viral
replic
studi
use
control
support
role
bind
downstream
major
group
hrv
signal
contrast
hrv
signal
event
depend
replic
eg
activ
bind
hrv
surfac
receptor
variou
cell
type
initi
signal
event
lead
product
cytokin
chemokin
interestingli
cell
surfac
receptor
recogn
strain
yet
identifi
appear
differ
use
innat
immun
respons
hrv
like
major
determin
infect
sever
ill
addit
import
ldlr
receptor
hrv
signal
also
evid
role
membran
bound
cytoplasm
rna
sens
molecul
local
endosom
plasma
membran
bind
rna
respect
infect
epitheli
cell
major
group
serotyp
shown
increas
express
also
report
promot
activ
attenu
level
knock
epitheli
cell
transfect
hek
lead
increas
product
studi
support
role
hrv
signal
although
mani
studi
model
signal
event
induc
hrv
synthet
dsrna
ligand
polyi
c
util
epitheli
cell
line
instead
primari
cultur
airway
cell
notabl
signal
event
initi
polyi
c
hrv
signific
differ
sever
intracellular
molecul
also
serv
detect
hrv
includ
dsrnaprotein
kinas
receptor
pkr
cytoplasm
rna
helicas
retino
acid
induc
gene
melanoma
gene
exampl
studi
chen
colleagu
found
pkr
activ
essenti
ifn
releas
primari
epitheli
cell
group
provid
evid
tlr
adapt
protein
trif
also
contribut
cytokin
releas
recent
studi
found
constitut
express
airway
epitheli
cell
activ
lead
induct
three
molecul
found
cooper
upregul
innat
ifn
respons
hrv
infect
investig
report
less
import
molecul
detect
picornaviru
rna
mani
event
detect
cell
challeng
viru
treat
uv
radiat
thu
appear
requir
viral
replic
respons
includ
express
andor
releas
chemokin
cytokin
ifn
antivir
pathway
mucin
defensin
matrix
find
suggest
activ
replic
import
compon
signal
howev
uv
inactiv
disrupt
coat
protein
viru
affect
bind
viru
host
cell
author
unpublish
data
addit
cell
activ
initi
viral
rna
express
hrv
proteas
cystein
proteas
express
activ
infect
cell
also
link
cell
activ
express
sever
cytokin
includ
respons
infect
bind
hrv
surfac
receptor
variou
cell
type
induc
specif
signal
event
lead
cell
activ
major
studi
perform
epitheli
cell
see
fig
exampl
bind
epitheli
cell
induc
activ
tyrosin
kinas
src
syk
subsequ
activ
phosphatidylinositol
akt
signal
cascad
activ
major
group
hrv
infect
link
activ
subsequ
releas
epitheli
cell
support
role
pathway
mice
inocul
minor
group
hrv
increas
akt
phosphoryl
lung
abrog
pretreat
inhibitor
furthermor
syk
activ
critic
protein
kinas
mapk
activ
subsequ
express
hrv
activ
activ
also
contribut
product
vascular
endotheli
growth
factor
vegf
express
angiogen
factor
vegf
hrv
infect
also
regul
extracellular
mapk
pathway
critic
induct
express
convers
kinas
inhibit
enhanc
express
numer
transcript
factor
link
event
epitheli
cell
includ
activ
member
nuclear
factor
signal
transduc
activ
transcript
stat
ifn
regulatori
factor
irf
famili
transcript
factor
shown
numer
group
upstream
epitheli
cell
mediat
releas
activ
requir
transloc
nucleu
liber
infect
epitheli
cell
major
group
hrv
increas
bind
activ
implic
icam
express
activ
requir
transloc
nucleu
liber
hewson
colleagu
found
cell
infect
hrv
nuclei
pkr
report
associ
nucleu
regul
express
induct
hrv
also
found
indirectli
depend
requir
induct
mmp
activ
epitheli
cell
postul
result
rapid
superoxid
product
activ
pkr
signal
cascad
janu
kinas
jak
stat
signal
cascad
also
implic
signal
chen
colleagu
report
abl
induc
phosphoryl
preincub
inhibitor
attenu
gene
express
human
tracheobronchi
epitheli
cell
express
thought
depend
hrv
replic
subsequ
releas
interferon
role
irf
transcript
factor
famili
signal
event
epitheli
cell
support
induct
releas
major
group
hrv
downstream
wherea
express
minor
group
gene
express
implic
induct
express
furthermor
hrv
induc
releas
shown
depend
infect
epitheli
cell
hrv
also
induc
releas
reactiv
oxygen
speci
propos
upstream
releas
subset
mediat
rhinoviru
infect
lead
proteolyt
activ
xanthin
oxidas
deplet
intracellular
reduc
glutathion
induc
rapid
increas
intracellular
superoxid
anion
propos
upstream
activ
express
convers
anoth
free
radic
nitric
oxid
implic
suppress
event
epitheli
cell
activ
express
autocrineparacrin
signal
hrv
exposur
also
attribut
mediat
releas
neutral
shown
significantli
block
induct
numer
gene
upregul
major
group
hrv
support
role
releas
subsequ
gene
transcript
furthermor
mucin
express
respons
hrv
infect
propos
result
epiderm
growth
factor
receptor
egfr
activ
increas
egfr
ligand
contrast
numer
hrv
signal
studi
epitheli
cell
much
less
known
signal
mechan
induc
upon
hrv
bind
immun
cell
signal
mechan
elucid
leukocyt
date
determin
monocyt
cell
consid
replic
hrv
observ
airway
macrophag
blood
monocyt
signal
pathway
like
vari
consider
epitheli
cell
signal
thought
reli
heavili
viral
replic
compar
elabor
signal
mechan
elucid
epitheli
cell
signal
monocyt
cell
extens
explor
exclus
perform
major
group
hrv
see
fig
observ
protein
releas
primari
monocyt
cell
link
activ
transcript
factor
phosphoryl
transcript
activ
mapk
report
involv
releas
monocyt
cell
furthermor
induc
signific
increas
releas
tyrosin
phosphoryl
human
monocyt
neutral
type
ifn
receptor
inhibit
jak
mapk
activ
strongli
attenu
phosphoryl
releas
also
observ
phosphoryl
jnk
transcript
factor
cyclicamp
respons
bind
protein
creb
treatment
monocyt
cell
consequ
phosphoryl
event
yet
elucid
unpublish
data
epitheli
cell
serv
host
cell
viral
replic
initi
numer
innat
immun
respons
tabl
epitheli
cell
gener
releas
ifn
rapidli
respons
viral
infect
first
line
defens
inde
infect
epitheli
cell
hrv
induc
express
releas
multipl
ifn
combat
infect
addit
releas
ifn
epitheli
cell
produc
larg
array
cytokin
chemokin
inflammatori
mediat
induc
influx
leukocyt
caus
respiratori
inflamm
facilit
signal
express
certain
signal
molecul
transcript
factor
epitheli
cell
induc
respons
hrv
addit
exposur
epitheli
cell
hrv
also
induc
releas
growth
factor
serv
prolong
life
infiltr
leukocyt
may
contribut
airway
remodel
seen
lung
asthmat
worth
note
comprehens
gene
express
profil
provid
studi
monocyt
macrophag
lymphocyt
presum
dc
secret
proinflammatori
cytokin
respons
hrv
infect
tabl
cytokin
activ
cell
environ
potent
induc
adhes
molecul
furthermor
exposur
leukocyt
hrv
also
modul
express
surfac
adhes
receptor
alter
leukocyt
migrat
concentr
chemotact
factor
monocyt
lymphocyt
basophil
markedli
elev
balf
asthmat
individu
compar
balf
control
individu
moreov
level
cytokin
chemotact
factor
cell
nk
cell
lymphocyt
associ
patholog
asthmat
interestingli
observ
monocyt
cell
ie
peripher
blood
monocyt
balf
macrophag
abl
robustli
releas
upon
treatment
support
notion
phagocyt
sourc
chemokin
natur
cold
atop
asthma
model
experiment
hrv
inocul
balf
macrophag
induc
express
mediat
ie
indic
less
inflammatori
fibrot
macrophag
popul
support
domin
environ
lymphocyt
recruit
upper
lower
airway
earli
stage
viral
respiratori
infect
presum
innat
adapt
immun
respons
serv
limit
extent
infect
clear
epitheli
cell
consist
report
sever
viral
lower
respiratori
infect
immunocompromis
patient
respons
hrv
direct
epitop
share
among
multipl
serotyp
epitop
hrv
infect
peripher
blood
mononuclear
cell
shown
inhibit
lymphocyt
prolif
respons
inhibit
product
costimulatori
molecul
induct
hrv
replic
small
percentag
epitheli
cell
given
time
gener
caus
littl
cytopatholog
primari
cell
consid
event
thought
find
suggest
patholog
exhibit
upon
respiratori
infect
may
consequ
cytokin
elabor
recruit
inflammatori
cell
close
proxim
epitheli
cell
macrophag
vivo
suggest
intercellular
interact
two
cell
type
would
like
enhanc
antivir
respons
hrv
infect
support
hypothesi
vegf
induct
bronchial
epitheli
cell
enhanc
presenc
mononuclear
cell
supernat
furthermor
human
monocyt
bronchial
epitheli
cell
promot
synergist
augment
protein
releas
follow
challeng
transfer
condit
media
monocyt
cell
epitheli
cultur
induc
robust
releas
epitheli
cell
attenu
type
ifn
receptor
block
antibodi
could
recapitul
addit
data
indic
epitheli
releas
hrv
infect
augment
monocyt
mechan
involv
type
ifn
provid
evid
crosstalk
immun
cell
epithelium
hrv
infect
sever
mechan
propos
explain
interact
fig
first
underli
defect
immun
regul
epitheli
barrier
function
could
promot
viral
infect
allergyasthma
possibl
abnorm
antivir
activ
asthma
exist
evalu
number
investig
measur
cytokin
respons
peripher
blood
mononuclear
cell
exampl
respons
allerg
individu
found
invers
relat
viral
shed
interestingli
evid
mononuclear
cell
product
may
impair
allerg
asthma
respons
subject
asthma
posit
associ
measur
pulmonari
function
furthermor
airway
sputum
cell
domin
respons
ratio
mrna
associ
milder
cold
rapid
clearanc
viru
addit
differ
mononuclear
cell
sputum
cell
ifn
respons
evid
epitheli
cell
ifn
respons
may
also
diminish
asthma
first
seri
experi
wark
et
al
use
bronchoscopi
obtain
bronchial
epitheli
cell
bec
cultur
normal
asthmat
subject
use
bec
highli
relev
cell
primari
site
hrv
infect
lower
airway
use
model
wark
et
al
found
replic
increas
respons
diminish
bec
asthmat
patient
addit
hrv
bec
cultur
asthmat
subject
reduc
viru
replic
parallel
observ
contoli
et
al
found
decreas
respons
bronchoalveolar
airway
cell
asthmat
subject
addit
experiment
inocul
fall
lung
function
ie
forc
expiratori
volum
invers
proport
gener
previous
note
data
suggest
airway
cell
asthma
patient
defect
antivir
respons
reflect
reduc
gener
ifn
investig
support
conclus
two
recent
studi
unabl
confirm
epitheli
cell
ifn
respons
defici
asthma
moreov
date
studi
experiment
inocul
volunt
found
signific
differ
hrv
shed
relat
asthma
mani
factor
contribut
differ
observ
particularli
sever
asthma
studi
consequ
addit
studi
patient
asthma
natur
acquir
cold
need
resolv
differ
one
featur
respiratori
allergi
asthma
increas
allerg
effector
cell
eosinophil
mast
cell
airway
interact
hrv
cell
involv
allerg
respons
studi
vitro
hrv
bind
eosinophil
littl
evid
cell
activ
measur
releas
granular
protein
howev
eosinophil
abl
stimul
prolifer
clone
evid
hrv
infect
enhanc
eosinophil
respons
allergen
challeng
vivo
common
cold
infect
gener
associ
increas
histamin
nasal
secret
howev
hrv
infect
mast
cell
line
enhanc
respons
vitro
viral
infect
allerg
inflamm
damag
airway
epithelium
could
lead
synergist
effect
one
hand
viral
infect
compromis
barrier
function
airway
epithelium
could
lead
enhanc
absorpt
allergen
andor
irrit
across
airway
wall
increas
allerg
inflamm
altern
hrv
replic
vitro
greater
damag
epithelium
impli
damag
airway
epithelium
could
promot
greater
viral
replic
sever
clinic
ill
concept
could
also
appli
pollut
explain
exposur
toxic
agent
eg
tobacco
smoke
also
increas
risk
viral
wheez
notabl
evid
epitheli
repair
mechan
abnorm
asthma
suggest
noxiou
environment
stimuli
could
compromis
epitheli
barrier
function
thu
disproportion
increas
suscept
hrv
replic
asthmat
addit
airway
epithelium
asthma
distinct
featur
includ
increas
number
goblet
cell
interestingli
laboratori
evid
hrv
replic
enhanc
cell
second
experiment
evid
allerg
inflamm
could
promot
sever
viral
ill
recent
mechanist
studi
provid
evid
antagonist
relationship
allerg
inflamm
antivir
immun
exampl
gill
colleagu
demonstr
cross
link
ige
receptor
plasmacytoid
dc
major
contributor
antivir
ifn
respons
lead
inhibit
secret
dc
also
play
key
role
allerg
sensit
direct
develop
naiv
cell
versu
cell
latter
secret
cytokin
lead
ige
product
ie
eosinophil
inflamm
eg
thymic
stromal
lymphopoeitin
tslp
cytokin
act
dc
promot
differenti
cytokin
induc
hrv
infect
mechan
furthermor
secret
tslp
enhanc
suggest
viru
infect
allerg
airway
could
intensifi
inflammatori
respons
interestingli
tslp
respons
epitheli
cell
may
reciproc
regul
suggest
high
level
tslp
airway
could
potenti
impair
antivir
respons
final
allerg
inflamm
viral
infect
synergist
enhanc
mucu
secret
mice
excess
secret
mucu
lead
plug
closur
airway
asthma
third
viral
infect
could
enhanc
allerg
inflamm
hrv
two
proteas
hrv
proteas
enhanc
inflamm
mous
model
allerg
inflamm
anim
model
also
suggest
viral
respiratori
infect
earli
life
may
establish
pattern
overproduct
key
cytokin
lead
suboptim
antivir
respons
increas
risk
respiratori
allergi
chang
airway
structur
promot
asthma
similarli
clinic
studi
acut
exacerb
asthma
circul
pbmc
increas
express
gene
dc
express
chemokin
suggest
innat
antivir
respons
link
enhanc
activ
allerg
inflamm
viral
infect
allerg
airway
inflamm
synergist
effect
risk
develop
asthma
pathogenesi
acut
exacerb
asthma
understand
interact
innat
antivir
respons
inflamm
would
great
util
identifi
mechan
asthma
onset
acut
airway
obstruct
regardless
direction
interact
find
strongli
suggest
optim
strategi
prevent
wheez
would
twofold
improv
antivir
respons
ii
reduc
allerg
sensit
inflamm
